SG10201500298PA - Inhibitors of flaviviridae viruses - Google Patents
Inhibitors of flaviviridae virusesInfo
- Publication number
- SG10201500298PA SG10201500298PA SG10201500298PA SG10201500298PA SG10201500298PA SG 10201500298P A SG10201500298P A SG 10201500298PA SG 10201500298P A SG10201500298P A SG 10201500298PA SG 10201500298P A SG10201500298P A SG 10201500298PA SG 10201500298P A SG10201500298P A SG 10201500298PA
- Authority
- SG
- Singapore
- Prior art keywords
- inhibitors
- flaviviridae viruses
- flaviviridae
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29557610P | 2010-01-15 | 2010-01-15 | |
| US35348110P | 2010-06-10 | 2010-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201500298PA true SG10201500298PA (en) | 2015-03-30 |
Family
ID=43538203
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201500298PA SG10201500298PA (en) | 2010-01-15 | 2011-01-14 | Inhibitors of flaviviridae viruses |
| SG2012051181A SG182475A1 (en) | 2010-01-15 | 2011-01-14 | Inhibitors of flaviviridae viruses |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012051181A SG182475A1 (en) | 2010-01-15 | 2011-01-14 | Inhibitors of flaviviridae viruses |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US8513298B2 (de) |
| EP (2) | EP2523950B1 (de) |
| JP (2) | JP5868872B2 (de) |
| KR (1) | KR101727776B1 (de) |
| CN (1) | CN102712633B (de) |
| AP (1) | AP3576A (de) |
| AR (1) | AR080001A1 (de) |
| AU (1) | AU2011205744B2 (de) |
| BR (1) | BR112012017382A2 (de) |
| CA (1) | CA2785567C (de) |
| CL (1) | CL2012001960A1 (de) |
| CR (1) | CR20120417A (de) |
| EA (1) | EA021196B1 (de) |
| EC (1) | ECSP12012104A (de) |
| ES (1) | ES2626150T3 (de) |
| IL (1) | IL220545B (de) |
| MX (1) | MX2012008211A (de) |
| NZ (1) | NZ600817A (de) |
| PE (1) | PE20130281A1 (de) |
| PL (1) | PL2523950T3 (de) |
| PT (1) | PT2523950T (de) |
| SG (2) | SG10201500298PA (de) |
| SI (1) | SI2523950T1 (de) |
| TW (1) | TWI491609B (de) |
| UY (1) | UY33183A (de) |
| WO (1) | WO2011088345A1 (de) |
| ZA (1) | ZA201205248B (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010276441B2 (en) * | 2009-07-21 | 2015-07-02 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| KR20120081123A (ko) | 2009-09-09 | 2012-07-18 | 길리애드 사이언시즈, 인코포레이티드 | 플라비비리대 바이러스의 억제제 |
| SG10201500298PA (en) | 2010-01-15 | 2015-03-30 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
| ES2543105T3 (es) | 2010-01-15 | 2015-08-14 | Gilead Sciences, Inc. | Inhibidores de virus flaviviridae |
| WO2012087596A1 (en) | 2010-12-20 | 2012-06-28 | Gilead Sciences, Inc. | Combinations for treating hcv |
| DE102011003295A1 (de) * | 2011-01-28 | 2012-08-02 | Kiekert Ag | Kraftfahrzeugschloss |
| EP2734515B1 (de) | 2011-07-13 | 2015-11-04 | Gilead Sciences, Inc. | Thiophen-2-carbonsäure derivate als inhibitoren von flaviviridae-viren |
| CN106166160A (zh) * | 2011-09-16 | 2016-11-30 | 吉利德制药有限责任公司 | 用于治疗hcv的组合物 |
| CN103087052A (zh) * | 2011-10-31 | 2013-05-08 | 上海壹志医药科技有限公司 | 噻吩衍生物及其药物用途 |
| SI2861604T1 (sl) * | 2012-06-08 | 2017-05-31 | Gilead Sciences, Inc. | Makrociklični inhibitorji flavivirusov |
| AR091279A1 (es) | 2012-06-08 | 2015-01-21 | Gilead Sciences Inc | Inhibidores macrociclicos de virus flaviviridae |
| NZ703066A (en) | 2012-06-08 | 2016-10-28 | Gilead Sciences Inc | Macrocyclic inhibitors of flaviviridae viruses |
| US8927741B2 (en) | 2012-08-17 | 2015-01-06 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| US8841340B2 (en) * | 2012-08-17 | 2014-09-23 | Gilead Sciences, Inc. | Solid forms of an antiviral compound |
| US8759544B2 (en) | 2012-08-17 | 2014-06-24 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
| US20140212491A1 (en) | 2013-01-31 | 2014-07-31 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
| US10190162B2 (en) | 2014-10-23 | 2019-01-29 | Complete Genomics, Inc. | Signal confinement sequencing (SCS) and nucleotide analogues for signal confinement sequencing |
| BR112017013858A2 (pt) | 2014-12-26 | 2018-02-27 | Univ Emory | n4-hidroxicitidina e derivados e usos antivirais relacionados aos mesmos |
| BR112018072298A2 (pt) * | 2016-05-02 | 2019-02-12 | Florida State University Research Foundation, Inc. | tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase |
| EP3455218A4 (de) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | Mit c3-kohlenstoff verknüpfte glutarimiddegronimere zum zielproteinabbau |
| WO2017197036A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Spirocyclic degronimers for target protein degradation |
| EP3454856A4 (de) | 2016-05-10 | 2019-12-25 | C4 Therapeutics, Inc. | Heterocyclische degronimere für zielproteinabbau |
| PL3464336T3 (pl) | 2016-06-01 | 2022-05-16 | Athira Pharma, Inc. | Związki |
| KR102626210B1 (ko) | 2017-12-07 | 2024-01-18 | 에모리 유니버시티 | N4-하이드록시사이티딘 및 유도체 및 이와 관련된 항-바이러스 용도 |
| CN108096562B (zh) * | 2017-12-25 | 2021-05-11 | 武汉百药联科科技有限公司 | 20s蛋白酶体抑制剂在制备治疗日本乙型脑炎病毒感染的药物中的用途 |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US743729A (en) * | 1903-03-02 | 1903-11-10 | William Clark Kirk | Work-support for lathes. |
| US3533088A (en) * | 1967-10-31 | 1970-10-06 | Rca Corp | Control circuit for memory |
| US4714839A (en) * | 1986-03-27 | 1987-12-22 | Advanced Micro Devices, Inc. | Control circuit for disabling or enabling the provision of redundancy |
| US4721868A (en) * | 1986-09-23 | 1988-01-26 | Advanced Micro Devices, Inc. | IC input circuitry programmable for realizing multiple functions from a single input |
| JPH02146195A (ja) * | 1988-11-28 | 1990-06-05 | Nec Corp | 半導体記憶装置 |
| JPH03214500A (ja) * | 1990-01-18 | 1991-09-19 | Sony Corp | メモリ装置 |
| JP2575919B2 (ja) * | 1990-03-22 | 1997-01-29 | 株式会社東芝 | 半導体記憶装置の冗長回路 |
| US5959445A (en) * | 1995-09-29 | 1999-09-28 | Intel Corporation | Static, high-sensitivity, fuse-based storage cell |
| US5861421A (en) * | 1995-12-21 | 1999-01-19 | Smithkline Beecham Corporation | 4,4-(disubstituted) cyclohexan-1-one monomers and related compounds |
| US6037799A (en) * | 1995-12-29 | 2000-03-14 | Stmicroelectronics, Inc. | Circuit and method for selecting a signal |
| US20050119332A1 (en) * | 1998-03-12 | 2005-06-02 | Lone Jeppesen | Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
| US20020002199A1 (en) * | 1998-03-12 | 2002-01-03 | Lone Jeppesen | Modulators of protein tyrosine phosphatases (ptpases) |
| US6175261B1 (en) * | 1999-01-07 | 2001-01-16 | Texas Instruments Incorporated | Fuse cell for on-chip trimming |
| US6275063B1 (en) * | 1999-08-24 | 2001-08-14 | Micron Technology, Inc. | Method and apparatus for limited reprogrammability of fuse options using one-time programmable elements |
| US6353336B1 (en) * | 2000-03-24 | 2002-03-05 | Cypress Semiconductor Corp. | Electrical ID method for output driver |
| WO2002100846A1 (en) | 2001-06-11 | 2002-12-19 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| EP2206709A3 (de) * | 2001-06-11 | 2011-06-29 | Virochem Pharma Inc. | Thiophenderivate als antivirale Mittel gegen Flavivirus-Infektion |
| KR100481179B1 (ko) * | 2002-09-10 | 2005-04-07 | 삼성전자주식회사 | 퓨즈를 구비한 회로 및 이를 이용한 반도체 장치 |
| JP3884374B2 (ja) * | 2002-12-06 | 2007-02-21 | 株式会社東芝 | 半導体装置 |
| MXPA05006196A (es) | 2002-12-10 | 2006-01-27 | Virochem Pharma Inc | Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus. |
| KR101058696B1 (ko) * | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
| KR100569585B1 (ko) * | 2003-12-05 | 2006-04-10 | 주식회사 하이닉스반도체 | 내부 전원 드라이버 제어 회로 |
| DE10359791A1 (de) * | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
| WO2005081954A2 (en) * | 2004-02-25 | 2005-09-09 | Wyeth | Inhibitors of protein tyrosine phosphatase 1b |
| JP2007531757A (ja) * | 2004-03-30 | 2007-11-08 | カイロン コーポレイション | 抗癌剤としての置換チオフェン誘導体 |
| DE102005028077A1 (de) | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
| DE102004061746A1 (de) | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
| AP2007004245A0 (en) * | 2005-05-13 | 2007-12-31 | Virochem Pharma Inc | Compounds and methods for the treatment or prevention of flavivirus infections |
| NZ564923A (en) | 2005-07-07 | 2012-02-24 | Athlomics Pty Ltd | Polynucleotide marker genes and their expression, for diagnosis of endotoxemia |
| GB0602046D0 (en) | 2006-02-01 | 2006-03-15 | Smithkline Beecham Corp | Compounds |
| JP2009526794A (ja) | 2006-02-15 | 2009-07-23 | サノフィ−アベンティス | 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用 |
| EA201101492A1 (ru) | 2006-11-15 | 2012-09-28 | Вирокем Фарма Инк. | Аналоги тиофена для лечения или предупреждения флавивирусных инфекций |
| JP2010510191A (ja) * | 2006-11-17 | 2010-04-02 | スミスクライン ビーチャム コーポレーション | 抗ウイルス剤としての２−カルボキシチオフェン誘導体 |
| KR20110098779A (ko) | 2008-12-03 | 2011-09-01 | 프레시디오 파마슈티칼스, 인코포레이티드 | Ｈｃｖ ｎｓ5ａ의 억제제 |
| AU2010276441B2 (en) * | 2009-07-21 | 2015-07-02 | Gilead Sciences, Inc. | Inhibitors of Flaviviridae viruses |
| KR20120081123A (ko) | 2009-09-09 | 2012-07-18 | 길리애드 사이언시즈, 인코포레이티드 | 플라비비리대 바이러스의 억제제 |
| AU2010326225A1 (en) | 2009-11-25 | 2012-06-07 | Vertex Pharmaceuticals Incorporated | 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections |
| SG10201500298PA (en) | 2010-01-15 | 2015-03-30 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
| ES2543105T3 (es) * | 2010-01-15 | 2015-08-14 | Gilead Sciences, Inc. | Inhibidores de virus flaviviridae |
| AU2011276526A1 (en) | 2010-06-28 | 2013-01-10 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
| EP2734515B1 (de) | 2011-07-13 | 2015-11-04 | Gilead Sciences, Inc. | Thiophen-2-carbonsäure derivate als inhibitoren von flaviviridae-viren |
-
2011
- 2011-01-14 SG SG10201500298PA patent/SG10201500298PA/en unknown
- 2011-01-14 EP EP11700988.6A patent/EP2523950B1/de active Active
- 2011-01-14 PT PT117009886T patent/PT2523950T/pt unknown
- 2011-01-14 KR KR1020127021314A patent/KR101727776B1/ko active IP Right Grant
- 2011-01-14 BR BR112012017382A patent/BR112012017382A2/pt not_active Application Discontinuation
- 2011-01-14 PL PL11700988T patent/PL2523950T3/pl unknown
- 2011-01-14 AP AP2012006414A patent/AP3576A/xx active
- 2011-01-14 JP JP2012549122A patent/JP5868872B2/ja active Active
- 2011-01-14 AR ARP110100126A patent/AR080001A1/es unknown
- 2011-01-14 NZ NZ600817A patent/NZ600817A/en not_active IP Right Cessation
- 2011-01-14 ES ES11700988.6T patent/ES2626150T3/es active Active
- 2011-01-14 MX MX2012008211A patent/MX2012008211A/es active IP Right Grant
- 2011-01-14 TW TW100101437A patent/TWI491609B/zh active
- 2011-01-14 PE PE2012000999A patent/PE20130281A1/es not_active Application Discontinuation
- 2011-01-14 SG SG2012051181A patent/SG182475A1/en unknown
- 2011-01-14 WO PCT/US2011/021335 patent/WO2011088345A1/en active Application Filing
- 2011-01-14 CA CA2785567A patent/CA2785567C/en active Active
- 2011-01-14 EP EP17160365.7A patent/EP3219713A1/de not_active Withdrawn
- 2011-01-14 AU AU2011205744A patent/AU2011205744B2/en active Active
- 2011-01-14 CN CN201180005975.8A patent/CN102712633B/zh active Active
- 2011-01-14 EA EA201290576A patent/EA021196B1/ru not_active IP Right Cessation
- 2011-01-14 UY UY0001033183A patent/UY33183A/es not_active Application Discontinuation
- 2011-01-14 US US13/007,150 patent/US8513298B2/en active Active
- 2011-01-14 SI SI201131169A patent/SI2523950T1/sl unknown
-
2012
- 2012-06-21 IL IL220545A patent/IL220545B/en not_active IP Right Cessation
- 2012-07-13 ZA ZA2012/05248A patent/ZA201205248B/en unknown
- 2012-07-13 CL CL2012001960A patent/CL2012001960A1/es unknown
- 2012-08-10 CR CR20120417A patent/CR20120417A/es unknown
- 2012-08-13 EC ECSP12012104 patent/ECSP12012104A/es unknown
-
2013
- 2013-07-11 US US13/939,695 patent/US9321753B2/en active Active
-
2015
- 2015-11-02 JP JP2015215450A patent/JP2016041732A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3576A (en) | Inhibitors of flaviviridae viruses | |
| HK1171443A1 (en) | Inhibitors of flaviviridae viruses | |
| AP3409A (en) | Inhibitors of flaviviridae viruses | |
| HK1191000A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| HK1212349A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| HK1211285A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| HK1210483A1 (en) | Macrocyclic inhibitors of flaviviridae viruses | |
| HK1170740A1 (zh) | 黃病毒科病毒抑制劑 | |
| IL224369B (en) | Combinations of inhibitors for hepatitis c virus | |
| EP2575866A4 (de) | Hcv-ns5a-shemmer | |
| EP2575475A4 (de) | Hcv-ns5a-shemmer | |
| EP2678018A4 (de) | Kombination von kinasehemmern und verwendungen dafür | |
| HK1185763A1 (zh) | 丙型肝炎病毒抑制劑 | |
| EP2528436A4 (de) | Hemmer des hepatitis-c-virus | |
| EP2575819A4 (de) | Hemmer des hepatitis-c-virus | |
| ZA201206456B (en) | Uses of dgati inhibitors | |
| HK1200847A1 (en) | Inhibitors of hcv ns5a hcv ns5a | |
| EP2688901A4 (de) | Hemmer von 17-beta-hsd1, 17-beta-hsd3 und 17beta-hsd10 |